MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wenningmann, I.
Right arrow Articles by Dilger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenningmann, I.
Right arrow Articles by Dilger, J. P.

Vol. 60, Issue 4, 790-796, October 2001

The Kinetics of Inhibition of Nicotinic Acetylcholine Receptors by (+)-Tubocurarine and Pancuronium

Ingobert Wenningmann and James P. Dilger

Klinik für Anästhesiologie, Universität Bonn, Bonn, Germany (I.W.); and Departments of Anesthesiology and Physiology & Biophysics, State University of New York at Stony Brook, Stony Brook, New York

Equilibrium conditions of neurotransmitter concentration and receptor binding are never achieved during synaptic transmission at the neuromuscular junction. Thus, it is important to determine the binding kinetics of drugs that act this synapse. Previous determinations of the dissociation rate of (+)-tubocurarine have produced inconsistent results ranging from 0.1 to 4000/s. Here, we used a direct approach to measure association (ell on) and dissociation (ell on) rates for two competitive antagonists (clinically used as nondepolarizing muscle relaxants), pancuronium and (+)-tubocurarine, at nicotinic acetylcholine receptors (nAChR). We made macroscopic current recordings from outside-out patches of BC3H-1 cells expressing embryonic mouse muscle nAChR. We used a three-tube rapid perfusion system to make timed applications of antagonists and acetylcholine to the patch. We made independent measurements of the equilibrium inhibition (IC50) and the kinetics of onset and recovery of antagonist inhibition at 20 to 23°C. Rate constants were calculated from the predictions of a single (high-affinity) site model of competitive inhibition. For pancuronium: IC50 = 5.5 ± 0.5 nM (mean ± S.D.), ell on = 2.7 ± 0.9 × 108 M-1 s-1, ell off = 2.1 ± 0.7 × 108/s. For (+)-tubocurarine: IC50 = 41 ± 2 nM, ell on = 1.2 ± 0.2 × 108 M-1 s-1, ell off = 5.9 ± 1.3/s. The kinetic results are consistent with the equilibrium results in that ell off/ell on is in good agreement with the IC50 values. All differences between the antagonists are significant at the p < 0.001 level. The higher affinity of pancuronium is caused by a faster association rate (2.2-fold) coupled with a slower dissociation rate (2.8-fold). The association rates of both antagonists are comparable with or greater than the association rate for acetylcholine binding to nAChR.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
M. Liu and J. P. Dilger
Site Selectivity of Competitive Antagonists for the Mouse Adult Muscle Nicotinic Acetylcholine Receptor
Mol. Pharmacol., January 1, 2009; 75(1): 166 - 173.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. Liu and J. P. Dilger
Synergy Between Pairs of Competitive Antagonists at Adult Human Muscle Acetylcholine Receptors
Anesth. Analg., August 1, 2008; 107(2): 525 - 533.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. Demazumder and J. P. Dilger
The kinetics of competitive antagonism of nicotinic acetylcholine receptors at physiological temperature
J. Physiol., February 15, 2008; 586(4): 951 - 963.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
M. Beato, V. Burzomato, and L. G. Sivilotti
The kinetics of inhibition of rat recombinant heteromeric {alpha}1beta glycine receptors by the low-affinity antagonist SR-95531
J. Physiol., April 1, 2007; 580(1): 171 - 179.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. K. Ford, M. Matchett, J. E. Krause, and W. Yu
The P2X3 Antagonist P1, P5-Di[inosine-5'] Pentaphosphate Binds to the Desensitized State of the Receptor in Rat Dorsal Root Ganglion Neurons
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 405 - 413.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. B. Hansen, Z. Radic', T. T. Talley, B. E. Molles, T. Deerinck, I. Tsigelny, and P. Taylor
Tryptophan Fluorescence Reveals Conformational Changes in the Acetylcholine Binding Protein
J. Biol. Chem., October 25, 2002; 277(44): 41299 - 41302.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Demazumder and J. P. Dilger
The Kinetics of Competitive Antagonism by Cisatracurium of Embryonic and Adult Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2001; 60(4): 797 - 807.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics